Moderna (MRNA) has had the highest return this year by a US stock with a market cap of $5B+, returning 643.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2026 | 643.28% |
Twist Bioscience (TWST) | 2026 | 381.5% |
Sandisk (SNDK) | 2026 | 371% |
10X Genomics (TXG) | 2026 | 329.86% |
Veradermics (MANE) | 2026 | 310.85% |
Immunitybio (IBRX) | 2026 | 310.4% |
Erasca (ERAS) | 2026 | 286.79% |
MaxLinear (MXL) | 2026 | 278.41% |
Kodiak Sciences (KOD) | 2026 | 255.36% |
Dell Technologies (DELL) | 2026 | 233.94% |
Oruka Therapeutics (ORKA) | 2026 | 219.6% |
Frontline (FRO) | 2026 | 208.29% |
Micron Technology (MU) | 2026 | 200% |
Spyre Therapeutics (SYRE) | 2026 | 194.75% |
PBF Energy (PBF) | 2026 | 190.68% |
Ringcentral (RNG) | 2026 | 182.36% |
Marathon Petroleum (MPC) | 2026 | 176.26% |
International Seaways (INSW) | 2026 | 166.28% |
Sasol (SSL) | 2026 | 164.92% |
HF Sinclair (DINO) | 2026 | 155.86% |
Valero Energy (VLO) | 2026 | 148.44% |
Hinge Health (HNGE) | 2026 | 146.17% |
MSG Knickerbockers (MSGK) | 2026 | 139.53% |
ASE Industrial Holding Co Ltd ADR (ASX) | 2026 | 139.34% |
Okta (OKTA) | 2026 | 138.94% |